期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
大豆皂苷调控miR-584-5p/HDAC1通路对子宫内膜癌细胞增殖及凋亡的影响 被引量:1
1
作者 帅仁亚 李晴宇 +1 位作者 范敏慧 徐炜 《中国现代医生》 2023年第33期35-40,共6页
目的研究大豆皂苷调控微小RNA-584-5p(microRNA-584-5p,miR-584-5p)/组蛋白去乙酰化酶1(histone deacetylasel,HDAC1)通路对子宫内膜癌(endometrial cancer,EC)细胞增殖及凋亡的影响。方法以终浓度Oltg/rml、20μg/ml、40μg/ml、80μg... 目的研究大豆皂苷调控微小RNA-584-5p(microRNA-584-5p,miR-584-5p)/组蛋白去乙酰化酶1(histone deacetylasel,HDAC1)通路对子宫内膜癌(endometrial cancer,EC)细胞增殖及凋亡的影响。方法以终浓度Oltg/rml、20μg/ml、40μg/ml、80μg/ml、120μg/ml、160μg/ml的大豆皂苷处理体外培养的人EC细胞系HEC-1-A,以细胞计数试剂盒8(cell counting Kit-8,CCK-8)法测定各浓度处理后的细胞活力,计算半数抑制浓度(half maximal inhibitory concentration,IC_(50))。将对数生长期的HEC-1-A细胞随机分为对照组、大豆皂苷组、miR-584-5p抑制剂组、大豆皂苷+miR-584-5p抑制剂组、大豆皂苷+miR-584-5p抑制剂阴性对照组,分组转染及用药处理后,以CCK-8法测定各组细胞活力;以流式细胞实验检测各组细胞凋亡率;以免疫印迹实验检测各组细胞HDAC1蛋白、增殖相关蛋白增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)及凋亡相关蛋白[天冬氨酸特异性半胱氨酸蛋白酶9(cysteine-containing aspartate-specific proteases 9,caspase-9)、B淋巴细胞瘤-2相关X蛋白(B-cell lymphoma-2-associated X protein,Bax)]表达;以实时荧光定量PCR(real-time quantitative PCR,qRT-PCR)实验检测各组细胞miR-584-5p与HDAC1 mRNA表达。结果不同浓度大豆皂苷可抑制HEC-1-A细胞生长,IC_(50)为98.56μg/ml。与对照组相比,大豆皂苷组与大豆皂苷+miR-584-5p抑制剂阴性对照组的细胞活力、PCNA蛋白表达、HDACl mRNA及蛋白表达降低(P<0.05),凋亡率、caspase-9及Bax蛋白表达、miR-584-5p表达增高(P<0.05);miR-584-5p抑制剂组的细胞各指标与大豆皂苷组相反。miR-584-5p抑制剂可减弱大豆皂苷对细胞各指标的作用。结论大豆皂苷可上调miR-584-5p表达,下调HDAC1表达,促使EC细胞凋亡,抑制其增殖。 展开更多
关键词 大豆皂苷 mir-584-5p/hdac1通路 子宫内膜癌细胞 增殖 凋亡
下载PDF
苯并[a]芘恶性转化细胞THBEc1中miR-584-5p/miR-211-5p/叉头框蛋白A1轴参与IDH1和HSPB1转录调控
2
作者 马雪 刘芷毓 +3 位作者 邢云昆 姚碧云 傅娟玲 赵鹏 《中国药理学与毒理学杂志》 CAS 北大核心 2023年第11期841-852,共12页
目的探索苯并[a]芘(BaP)恶性转化人支气管上皮细胞T-16HBE-C1(THBEc1)中微RNA(miRNA)调控叉头框蛋白A1(FOXA1)表达上调的机制,并筛选和验证FOXA1的潜在靶基因。方法利用TargetScan,ENCORI数据库和THBEc1细胞与非转化细胞16HBE间miRNA的... 目的探索苯并[a]芘(BaP)恶性转化人支气管上皮细胞T-16HBE-C1(THBEc1)中微RNA(miRNA)调控叉头框蛋白A1(FOXA1)表达上调的机制,并筛选和验证FOXA1的潜在靶基因。方法利用TargetScan,ENCORI数据库和THBEc1细胞与非转化细胞16HBE间miRNA的二代测序(NGS)结果,综合预测靶向调控FOXA1的miRNA,并通过实时荧光定量PCR(RT-qPCR)进一步筛选预测的miRNA。采用miRNA模拟物(mimics)转染THBEc1细胞,Western印迹法测定FOXA1蛋白表达水平,对靶向调控FOXA1的miRNA进行鉴定。利用hTF,JASPAR和ENCODE数据库结合FOXA1敲除细胞THBEc1-ΔFOXA1-c34和对照细胞THBEc1-ctrl间mRNA的NGS结果,综合预测FOXA1的潜在靶基因。利用RT-qPCR进一步对预测的靶基因[跨膜蛋白98(TMEM98)、IKAROS家族锌指2(IKZF2)、异柠檬酸脱氢酶1(IDH1)、肿瘤坏死因子受体相关因子5(TRAF5)、骨形态发生蛋白2型受体(BMPR2)、热休克蛋白B1(HSPB1)、Runt相关转录因子2(RUNX2)、golgin A7家族成员B(GOLGA7B)和维甲酸相关孤核受体A(RORA)]进行筛选。通过转染过表达质粒构建稳定表达FOXA1的细胞模型THBEc1-ΔFOXA1-c34-oe,即FOXA1功能回补,并利用RT-qPCR和Western印迹法验证FOXA1的潜在靶基因。结果TargetScan和ENCORI数据库分别预测到213和145个可能靶向调控FOXA1的miRNA。NGS共发现351个miRNA在THBEc1细胞中表达下调(差异倍数<0.5,且错误发现率<0.05),其中hsa-miR-584-5p(miR-584-5p),hsa-miR-142-5p(miR-142-5p)和hsa-miR-211-5p(miR-211-5p)在上述2个数据库中均被预测可靶向调控FOXA1。RT-qPCR结果证实,THBEc1细胞中miR-584-5p,miR-142-5p和miR-211-5p表达水平显著低于16HBE细胞(P<0.01)。转染miR-584-5p模拟物或miR-211-5p模拟物均可显著下调THBEc1细胞FOXA1蛋白表达水平(P<0.01),而转染miR-142-5p模拟物对THBEc1细胞FOXA1蛋白表达水平无明显影响。THBEc1-ΔFOXA1-c34和THBEc1-ctrl细胞间的20个差异表达基因(差异倍数<0.5或>2,且错误发现率<0.05)被hTF,JASPAR和ENCODE数据库均预测为FOXA1的潜在靶基因。RT-qPCR结果显示,在THBEc1-ΔFOXA1-c34中,TMEM98,IKZF2,IDH1,TRAF5,BMPR2,HSPB1和RUNX2 mRNA表达水平显著下调(P<0.05,P<0.01),GOLGA7B和RORA mRNA表达水平显著上调(P<0.05,P<0.01);在THBEc1-ΔFOXA1-c34-oe中,IDH1和HSPB1的mRNA表达水平显著上调(P<0.01),余7个基因mRNA表达水平未见改变。Western印迹结果显示,THBEc1-ΔFOXA1-c34细胞中IDH1和HSPB1表达水平较THBEc1-ctrl均显著下调(P<0.01);而恢复FOXA1表达的THBEc1-ΔFOXA1-c34-oe细胞中IDH1和HSPB1表达水平较对照细胞THBEc1-ΔFOXA1-c34-ctrl均显著上调(P<0.01)。结论BaP恶性转化细胞THBEc1中miR-584-5p/miR-211-5p/FOXA1轴参与IDH1和HSPB1转录调控。 展开更多
关键词 苯并[A]芘 叉头框蛋白A1 mir-584-5p mir-211-5p 异柠檬酸脱氢酶1 热休克蛋白B1
下载PDF
Hepatitis C virus core protein-induced miR-93-5p upregulation inhibits interferon signaling pathway by targeting IFNAR1 被引量:2
3
作者 Chang-Long He Ming Liu +5 位作者 Zhao-Xia Tan Ya-Jun Hu Qiao-Yue Zhang Xue-Mei Kuang Wei-Long Kong Qing Mao 《World Journal of Gastroenterology》 SCIE CAS 2018年第2期226-236,共11页
AIM To investigate the mechanism by which hepatitis C virus(HCV) core protein-induced mi R-93-5 p up-regulation regulates the interferon(IFN) signaling pathway.METHODS HCV-1 b core protein was exogenously expressed in... AIM To investigate the mechanism by which hepatitis C virus(HCV) core protein-induced mi R-93-5 p up-regulation regulates the interferon(IFN) signaling pathway.METHODS HCV-1 b core protein was exogenously expressed in Huh7 cells using pc DNA3.1(+) vector. The expression of mi R-93-5 p and interferon receptor 1(IFNAR1) was measured using quantitative reverse transcriptionpolymerase chain reaction and Western blot. The protein expression and phosphorylation level of STAT1 were evaluated by Western blot. The overexpression and silencing of mi R-93-5 p and IFNAR1 were performed using mi R-93-5 p agomir and antagomir, and pc DNA3.1-IFNAR1 and IFNAR1 si RNA, respectively. Luciferase assay was used to identify whether IFNAR1 is a target of mi R-93-5 p. Cellular experiments were also conducted.RESULTS Serum mi R-93-5 p level was increased in patients with HCV-1 b infection and decreased to normal level after HCV-1 b clearance, but persistently increased in those with pegylated interferon-α resistance, compared with healthy subjects. Serum mi R-93-5 p expression had an AUC value of 0.8359 in distinguishing patients with pegylated interferon-α resistance from those with pegylated interferon-α sensitivity. HCV-1 b core protein increased mi R-93-5 p expression and induced inactivation of the IFN signaling pathway in Huh7 cells. Furthermore, IFNAR1 was identified as a direct target of mi R-93-5 p, and IFNAR1 restore could rescue mi R-93-5 p-reduced STAT1 phosphorylation, suggesting that the mi R-93-5 p-IFNAR1 axis regulates the IFN signaling pathway.CONCLUSION HCV-1 b core protein-induced mi R-93-5 p up-regulation inhibits the IFN signaling pathway by directly targeting IFNAR1, and the mi R-93-5 p-IFNAR1 axis regulates STAT1 phosphorylation. This axis may be a potential therapeutic target for HCV-1 b infection. 展开更多
关键词 HEpATITIS C virus mir-93-5p INTERFERON receptor 1 IFN signaling pathway
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部